This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $3,145.46 for the supply of 4,566,798,406 units of the prescription drug Vyvanse 10 mg capsules. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order is intended to fulfill the medical needs of military personnel, veterans, and other federal beneficiaries through the DLA's healthcare programs.
Generated 3/27/25, 9:47 AM